309 related articles for article (PubMed ID: 18625427)
21. The design of drugs for HIV and HCV.
De Clercq E
Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
[TBL] [Abstract][Full Text] [Related]
22. Treatment and vaccination for hepatitis C: present and future.
Jawaid A; Khuwaja AK
J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
[TBL] [Abstract][Full Text] [Related]
23. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
J Hepatol; 2006 Feb; 44(2):411-21. PubMed ID: 16364491
[No Abstract] [Full Text] [Related]
24. Boceprevir, an NS3 protease inhibitor of HCV.
Berman K; Kwo PY
Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
[TBL] [Abstract][Full Text] [Related]
25. Future therapy of hepatitis C.
McHutchison JG; Patel K
Hepatology; 2002 Nov; 36(5 Suppl 1):S245-52. PubMed ID: 12407600
[TBL] [Abstract][Full Text] [Related]
26. A primer on the molecular virology of hepatitis C.
Moradpour D; Blum HE
Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499
[TBL] [Abstract][Full Text] [Related]
27. Clinical trial investigates two experimental HCV drugs.
AIDS Patient Care STDS; 2010 Apr; 24(4):270. PubMed ID: 20402017
[No Abstract] [Full Text] [Related]
28. Approaches for the development of antiviral compounds: the case of hepatitis C virus.
Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ
Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196
[TBL] [Abstract][Full Text] [Related]
29. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
30. Mathematical modeling of HCV infection and treatment.
Dahari H; Shudo E; Ribeiro RM; Perelson AS
Methods Mol Biol; 2009; 510():439-53. PubMed ID: 19009281
[TBL] [Abstract][Full Text] [Related]
31. Future therapies for hepatitis C.
Pawlotsky JM; Gish RG
Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
[TBL] [Abstract][Full Text] [Related]
32. Convert hepatitis C virus into a non-enveloped virus like hepatitis A, by targeting its envelope rather than the RNA.
Helmy A
Med Hypotheses; 2006; 66(4):847-50. PubMed ID: 16229965
[TBL] [Abstract][Full Text] [Related]
33. Novel approaches for therapy of chronic hepatitis C.
Stauber RE; Stadlbauer V
J Clin Virol; 2006 Jun; 36(2):87-94. PubMed ID: 16546442
[TBL] [Abstract][Full Text] [Related]
34. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
Bartenschlager R
Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
[TBL] [Abstract][Full Text] [Related]
36. Treating patients with HCV genotype 1 and low viraemia: more than meets the eye.
Craxì A; Cammà C
J Hepatol; 2006 Jan; 44(1):4-7. PubMed ID: 16293337
[No Abstract] [Full Text] [Related]
37. Virology of hepatitis B and C viruses and antiviral targets.
Pawlotsky JM
J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
[TBL] [Abstract][Full Text] [Related]
38. Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy.
Lange CM; Sarrazin C; Zeuzem S
Aliment Pharmacol Ther; 2010 Jul; 32(1):14-28. PubMed ID: 20374226
[TBL] [Abstract][Full Text] [Related]
39. Excitement grows for potential revolution in hepatitis C virus treatment.
Opar A
Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
[No Abstract] [Full Text] [Related]
40. Acute hepatitis C: prevention and treatment.
Ozaras R; Tahan V
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]